Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Maury Raycroft's Stock Ratings
Jefferies Analyst
Maury Raycroft is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-8.30%
Smart Score
Overall Average Return Percentile
20th
Number of Ratings
89
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/02/2025 | CELC | Buy Now | Celcuity | $102.18 | 31.14% | $108 → $134 | Maintains | Buy | Get Alert | |
| 11/07/2025 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.53 | 35.22% | $10 → $21 | Upgrade | Hold → Buy | Get Alert | |
| 10/31/2025 | OPK | Buy Now | OPKO Health | $1.33 | 20.27% | $2 → $1.6 | Downgrade | Buy → Hold | Get Alert | |
| 10/30/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | 40.23% | $550 → $549 | Maintains | Buy | Get Alert | |
| 10/17/2025 | KZR | Buy Now | Kezar Life Sciences | $6.15 | 13.82% | $18 → $7 | Downgrade | Buy → Hold | Get Alert | |
| 09/22/2025 | KOD | Buy Now | Kodiak Sciences | $21.50 | -30.23% | → $15 | Initiates | → Buy | Get Alert | |
| 09/15/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | 40.49% | $453 → $550 | Maintains | Buy | Get Alert | |
| 07/07/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -1.92% | $328 → $384 | Maintains | Buy | Get Alert | |
| 06/24/2025 | CRDF | Buy Now | Cardiff Oncology | $2.35 | 48.94% | → $3.5 | Initiates | → Hold | Get Alert | |
| 03/11/2025 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 461.44% | $70 → $53 | Maintains | Buy | Get Alert | |
| 03/05/2025 | CMRX | Buy Now | Chimerix | — | — | $10 → $8.5 | Downgrade | Buy → Hold | Get Alert | |
| 02/10/2025 | CMPX | Buy Now | Compass Therapeutics | $5.07 | 57.79% | $7 → $8 | Maintains | Buy | Get Alert | |
| 12/31/2024 | SGMO | Buy Now | Sangamo Therapeutics | $0.44 | 574.31% | $7 → $3 | Maintains | Buy | Get Alert | |
| 12/06/2024 | MREO | Buy Now | Mereo BioPharma Group | $2.18 | 221.1% | → $7 | Initiates | → Buy | Get Alert | |
| 11/18/2024 | ERAS | Buy Now | Erasca | $3.50 | 71.35% | → $6 | Initiates | → Buy | Get Alert | |
| 08/13/2024 | INZY | Buy Now | Inozyme Pharma | — | — | $16 → $17 | Assumes | Buy → Buy | Get Alert | |
| 07/17/2024 | TNGX | Buy Now | Tango Therapeutics | $9.12 | 108.33% | → $19 | Initiates | → Buy | Get Alert | |
| 05/28/2024 | CALT | Buy Now | Calliditas Therapeutics | — | — | $58 → $39 | Downgrade | Buy → Hold | Get Alert | |
| 05/07/2024 | PRME | Buy Now | Prime Medicine | $4.01 | 274.06% | $23 → $15 | Assumes | Buy → Buy | Get Alert | |
| 03/22/2024 | DNTH | Buy Now | Dianthus Therapeutics | $41.92 | -6.97% | $22 → $39 | Maintains | Buy | Get Alert | |
| 03/13/2024 | CUE | Buy Now | Cue Biopharma | $0.46 | 1204.35% | → $6 | Initiates | → Buy | Get Alert | |
| 03/06/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 387.29% | $4 → $46 | Upgrade | Hold → Buy | Get Alert | |
| 03/05/2024 | MGX | Buy Now | Metagenomi | $1.82 | 1163.74% | → $23 | Initiates | → Buy | Get Alert | |
| 02/08/2024 | TPST | Buy Now | Tempest Therapeutics | $3.04 | 393.42% | → $15 | Initiates | → Buy | Get Alert | |
| 12/26/2023 | DNTH | Buy Now | Dianthus Therapeutics | $41.92 | -47.52% | → $22 | Initiates | → Buy | Get Alert | |
| 10/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $55 → $58 | Downgrade | Buy → Hold | Get Alert | |
| 08/04/2023 | BCRX | Buy Now | BioCryst Pharma | $7.57 | 45.32% | → $11 | Upgrade | Hold → Buy | Get Alert | |
| 07/31/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $104 → $172.5 | Downgrade | Buy → Hold | Get Alert | |
| 05/15/2023 | SPPI | Buy Now | Spectrum Pharma | — | — | $3.5 → $1.5 | Downgrade | Buy → Hold | Get Alert | |
| 05/12/2023 | ALLK | Buy Now | Allakos | — | — | $6 → $9 | Upgrade | Hold → Buy | Get Alert | |
| 01/31/2023 | CMPX | Buy Now | Compass Therapeutics | $5.07 | 57.79% | → $8 | Initiates | → Buy | Get Alert | |
| 01/04/2023 | VERA | Buy Now | Vera Therapeutics | $47.74 | -87.43% | $32 → $6 | Downgrade | Buy → Hold | Get Alert | |
| 11/29/2022 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | 9.95% | $92 → $75 | Maintains | Buy | Get Alert | |
| 11/22/2022 | IMGO | Buy Now | Imago BioSciences | — | — | $35 → $36 | Downgrade | Buy → Hold | Get Alert | |
| 10/03/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -40.74% | $218 → $232 | Maintains | Buy | Get Alert | |
| 09/12/2022 | RZLT | Buy Now | Rezolute | $1.65 | 566.63% | → $11 | Initiates | → Buy | Get Alert | |
| 09/02/2022 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | $28 → $20 | Downgrade | Buy → Hold | Get Alert | |
| 04/14/2022 | SRRA | Buy Now | Sierra Oncology | — | — | $39 → $55 | Downgrade | Buy → Hold | Get Alert | |
| 03/08/2022 | TYRA | Buy Now | Tyra Biosciences | $22.12 | 22.06% | $31 → $27 | Upgrade | Hold → Buy | Get Alert | |
| 12/22/2021 | ALLK | Buy Now | Allakos | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 12/02/2021 | BYSI | Buy Now | BeyondSpring | $1.91 | 161.57% | $38 → $5 | Downgrade | Buy → Hold | Get Alert | |
| 11/30/2021 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | $12 → $17 | Upgrade | Hold → Buy | Get Alert | |
| 11/08/2021 | TYRA | Buy Now | Tyra Biosciences | $22.12 | 40.14% | $19 → $31 | Downgrade | Buy → Hold | Get Alert | |
| 11/01/2021 | THRX | Buy Now | Theseus Pharmaceuticals | — | — | → $23 | Initiates | → Buy | Get Alert | |
| 10/11/2021 | TYRA | Buy Now | Tyra Biosciences | $22.12 | -14.1% | → $19 | Initiates | → Buy | Get Alert | |
| 09/07/2021 | CELC | Buy Now | Celcuity | $102.18 | -53.02% | → $48 | Initiates | → Buy | Get Alert | |
| 08/10/2021 | IMGO | Buy Now | Imago BioSciences | — | — | → $30 | Initiates | → Buy | Get Alert | |
| 08/06/2021 | BCRX | Buy Now | BioCryst Pharma | $7.57 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 07/09/2021 | ASLN | Buy Now | ASLAN Pharma | — | — | → $8 | Initiates | → Buy | Get Alert | |
| 06/08/2021 | VERA | Buy Now | Vera Therapeutics | $47.74 | — | — | Initiates | → Buy | Get Alert | |
| 06/01/2021 | VALN | Buy Now | Valneva | $8.43 | 327.05% | → $36 | Initiates | → Buy | Get Alert | |
| 05/27/2021 | SLDB | Buy Now | Solid Biosciences | $5.71 | 22.59% | → $7 | Initiates | → Buy | Get Alert | |
| 05/10/2021 | MRTX | Buy Now | Mirati Therapeutics | — | — | $208 → $196 | Upgrade | Hold → Buy | Get Alert | |
| 04/21/2021 | CRSP | Buy Now | CRISPR Therapeutics | $56.00 | 207.14% | → $172 | Upgrade | Hold → Buy | Get Alert | |
| 03/31/2021 | CMRX | Buy Now | Chimerix | — | — | → $21 | Initiates | → Buy | Get Alert | |
| 09/01/2020 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | → $22 | Initiates | → Buy | Get Alert | |
| 06/30/2020 | CALT | Buy Now | Calliditas Therapeutics | — | — | → $44 | Initiates | → Buy | Get Alert | |
| 02/24/2020 | BDTX | Buy Now | Black Diamond Therapeutic | $2.65 | 1673.18% | → $47 | Initiates | → Buy | Get Alert | |
| 02/07/2020 | BYSI | Buy Now | BeyondSpring | $1.91 | 1207.87% | → $25 | Initiates | → Buy | Get Alert | |
| 01/30/2020 | SBPH | Buy Now | Spring Bank | — | — | $28 → $1.5 | Downgrade | Buy → Hold | Get Alert | |
| 10/15/2019 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $128 → $254 | Maintains | Buy | Get Alert | |
| 09/09/2019 | MRTX | Buy Now | Mirati Therapeutics | — | — | $89 → $105 | Upgrade | Hold → Buy | Get Alert | |
| 08/01/2019 | CRSP | Buy Now | CRISPR Therapeutics | $56.00 | 14.29% | → $64 | Initiates | → Buy | Get Alert | |
| 10/09/2018 | SBPH | Buy Now | Spring Bank | — | — | → $28 | Initiates | → Buy | Get Alert | |
| 08/28/2018 | AFMD | Buy Now | Affimed | — | — | $1.8 → $4 | Upgrade | Hold → Buy | Get Alert | |
| 07/16/2018 | KZR | Buy Now | Kezar Life Sciences | $6.15 | 273.98% | → $23 | Initiates | → Buy | Get Alert | |
| 03/27/2018 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | -85.34% | → $10 | Initiates | → Buy | Get Alert | |
| 11/01/2017 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 359.12% | $36 → $42 | Maintains | Buy | Get Alert | |
| 09/06/2017 | BCRX | Buy Now | BioCryst Pharma | $7.57 | — | — | Upgrade | Hold → Buy | Get Alert | |
| 08/30/2017 | RETA | Buy Now | Reata Pharmaceuticals | — | — | → $44 | Initiates | → Buy | Get Alert | |
| 11/30/2016 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | -97.07% | $5 → $2 | Maintains | Hold | Get Alert | |
| 08/05/2016 | BCRX | Buy Now | BioCryst Pharma | $7.57 | -60.37% | $2 → $3 | Maintains | Hold | Get Alert | |
| 08/05/2016 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | — | — | Upgrade | Hold → Buy | Get Alert | |
| 06/06/2016 | MRTX | Buy Now | Mirati Therapeutics | — | — | $27 → $17 | Downgrade | Buy → Hold | Get Alert | |
| 05/31/2016 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 260.73% | → $33 | Initiates | → Hold | Get Alert | |
| 05/19/2016 | AFMD | Buy Now | Affimed | — | — | $5 → $4 | Maintains | Hold | Get Alert | |
| 03/10/2016 | MRTX | Buy Now | Mirati Therapeutics | — | — | $33 → $29 | Maintains | Buy | Get Alert | |
| 02/17/2016 | MRTX | Buy Now | Mirati Therapeutics | — | — | — | Assumes | → Buy | Get Alert | |
| 02/09/2016 | BCRX | Buy Now | BioCryst Pharma | $7.57 | -73.58% | $14 → $2 | Downgrade | Hold → Buy | Get Alert | |
| 01/06/2016 | BCRX | Buy Now | BioCryst Pharma | $7.57 | 84.96% | → $14 | Upgrade | Hold → Buy | Get Alert | |
| 10/15/2015 | BCRX | Buy Now | BioCryst Pharma | $7.57 | 32.11% | $12 → $10 | Maintains | Hold | Get Alert | |
| 10/15/2015 | AFMD | Buy Now | Affimed | — | — | $11 → $7 | Maintains | Hold | Get Alert | |
| 09/09/2015 | BCRX | Buy Now | BioCryst Pharma | $7.57 | 58.53% | → $12 | Initiates | → Hold | Get Alert | |
| 09/09/2015 | AFMD | Buy Now | Affimed | — | — | → $11 | Initiates | → Hold | Get Alert | |
| 06/22/2015 | AFMD | Buy Now | Affimed | — | — | $12 → $16 | Maintains | Buy | Get Alert | |
| 04/14/2015 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 03/27/2015 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $34 | Assumes | → Buy | Get Alert | |
| 12/18/2013 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $36 | Initiates | → Buy | Get Alert | |
| 12/18/2013 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | -78.01% | → $15 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved